期刊文献+

孕中期唐氏综合征筛查中血清标志物中位数倍数校正模型 被引量:5

MoM Correction Model of Maternal Serum Markers in Screening the Patients with Down Syndrome at Second Trimester
暂未订购
导出
摘要 目的探讨与建立适合我国人群孕中期唐氏综合征筛查的血清标志物中位数倍数校正模型。方法利用非线性加权回归法构建血清学指标与孕龄的回归模型,根据PRESS统计量和校正决定系数选取最优模型校正血清学指标,利用累积和图法与国外常用的筛查软件Lifecycle 3.0、2T软件内置的各中位数进行比较。结果血清学指标与孕龄间有较好的回归关系,利用自建模型校正后,孕中期孕妇甲胎蛋白、游离人绒毛膜促性腺激素和游离雌三醇的累积和图在0附近,而利用Lifecycle 3.0、2T软件内置的中位数校正后,甲胎蛋白、游离人绒毛膜促性腺激素和游离雌三醇的累积和图远远偏离0。结论基于我国人群建立的孕中期孕妇血清标志物中位数倍数校正模型比国外筛查软件中内置的中位数模型更适合我国孕中期孕妇的产前筛查。 Objective To establish appropriate correction models of serum markers for prenatal screening of the patients with Down syndrome at the second trimester.Methods Nonlinear Weighted Regression models were employed to regress maternal serum markers and gestational age.The optimal models were selected by PRESS Statistics and R2adj.Then the medians were compared with those using such screening software as Lifecycle 3.0 and 2T by cumulative sum plots.Results The optimal models between maternal serum markers and gestational age were well built.The cumulative sum of log10 (MoM of AFP),log10 (MoM of free β-HCG) and log10 (MoM of uE3) for the models was near to zero,while those values for Lifecycle 3.0 and 2T were far deviated from zero.Conclusion Our correction model for maternal serum markers is more applicable than the models built by Lifecycle 3.0 and 2T for Chinese population at the second trimester screening.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第1期67-69,73,共4页 Journal of China Medical University
基金 宁波市科技攻关项目(2005C100008) 浙江省医学扶持重点建设学科资助项目(07-F06) 浙江省重大科技专项(2007C13001)
关键词 唐氏综合征 产前筛查 中位数 校正模型 血清学指标 中国人群 Down syndrome prenatal screening median correction model serum marker Chinese population
  • 相关文献

参考文献7

  • 1Hsu JJ,Hsieh TT,Hsieh FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group [ J ]. Obstet Gynecol, 1996, 87(6) : 943-947.
  • 2江苏省计划生育委员会出生缺陷干预项目组.中位倍数法及其在产前筛查中的应用[J].中华妇产科杂志,2004,39(6):428-429. 被引量:18
  • 3Leung TN,Pang MW,Daljit SS. Fetal biometry in ethnic Chinese: biparietal diameter,head circumference,abdominal circumference and femur length [J]. Ultrasound Obstet Gynecol, 2008,31 (3) : 321-327.
  • 4NHS Fetal Anomaly Screening Programme. Median of the MoM-QA standard[EB/OL]. (2008-04-14) [2010-12-07]. http://fetalanoma- ly.screening.nhs.uk/standardsandpolicies.
  • 5Wang YY,Luo J,Zhu MW,et al. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Cau- casian populations[ J ]. Int J Gynaecol Obstet, 2006,94( 1 ) : 67-72.
  • 6许碧云,胡娅莉,张春延,张建伟,刘启兰,岳慧,茹彤,许争峰,朱瑞芳,张颖,仲晓玲,吴青梅.江苏地区孕中期唐氏综合征筛查母血清标志物中位倍数标化方法的探讨[J].中华医学遗传学杂志,2008,25(1):32-35. 被引量:20
  • 7边旭明,刘俊涛,戚庆炜,蒋宇林,李岩,刘善英,郝娜,周京,吕时铭,朱宝生,王和,许争锋,潘小英,廖灿,蔡艳,王华,王泽,朱军,胡娅莉.对孕中期妇女行血清学二联指标筛查胎儿唐氏综合征的多中心前瞻性研究[J].中华妇产科杂志,2008,43(11):805-809. 被引量:63

二级参考文献25

  • 1Hsu JJ, Hsieh TY, Hsieh FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol, 1996, 87:943-947.
  • 2Wang YY, Luo J, Zhu MW, et al. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.Int J Gynaecol Obstet, 2006, 94:67-72.
  • 3Onda T, Kitagawa M, Takeda O, et al.Triple marker screening in native Japanese women. Prenat Diagn, 1996, 16:713-717.
  • 4Hsu JJ, Chiu TH, Chen KC, et al.Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation. Changgeng Yi Xue Za Zhi, 1994, 17 : 309-315.
  • 5Barrels I, Hoppe-Sievert B,Boekel B, et al. Adjustment formulae for maternal sermn alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking. Prenat Diagn, 1993, 13:123-130.
  • 6Macri jN, Kasturi RV, Krantz DA, et al. Maternal serum alpha-fetoprotein (MsAFP) patient-specific risk reporting: its use and misuse. Am J Hum Genet, 1990, 46:587-590.
  • 7Hsu JJ, Shieh TT, Hsien FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free β-hCG: a report of the Taiwan Down syndrome screening group. Obstet Gynecol, 1996,87:943-947.
  • 8Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome. J Med Screen, 1997, 4:151-246.
  • 9Wald N J, Rodeck C, Hackshaw AK, et al. First and Second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) . Health Techol Assess, 2003, 7 : 1-77.
  • 10Watt HC, Wald N J, Smith D, et al. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn, 1996, 16:691-698.

共引文献93

同被引文献40

  • 1王艳华,庞泓,张戬,董贵章.沈阳地区孕中期产前筛查母血清标志物水平中位数的探讨[J].中国妇幼保健,2005,20(9):1141-1143. 被引量:6
  • 2胡序怀,彭左旗,罗军,唐振华,李哮天,朱明伟,刘兰女,杨素霞,马旭.uE_3在唐氏综合征孕中期多指标联合筛查风险预测中的效果评估[J].中国计划生育学杂志,2006,14(6):349-352. 被引量:5
  • 3王雪方,施云凤.杭州地区8516例孕中期妇女产前筛查回顾性分析[J].中国优生与遗传杂志,2006,14(7):51-52. 被引量:20
  • 4Kaur G,Srivastav J,Kaur A,et al.Maternal serum second trimester screening for chromosomal disorders and neural tube defects in a government hospital of North India[J].Prenat Diagn,2012,32(12):1192-1196.
  • 5Chedane C,Puissant H,Weil D,et al.Association between altered placental human chorionic gonadotrophin(h CG)production and the occurrence of cryptorchidism:a retrospective study[J].BMC Pediatr,2014,14:191.
  • 6PALOMAKI G E, HADDOW J E. Maternal serum alpha-fetoprotein, age, and Down syndrome risk[J]. Am J Obstet Gynecol, 1987, 156(2):460-463.
  • 7LEMESHOW S, HOSMER D W J. A review of goodness of fit statistics for use in the development of logistic regression models[J]. Am J Epidemiol, 1982, 115(1):92- 106.
  • 8HWA H L, MING T K, HSIEH F J, et al. Risk prediction for Down syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis[J]. Journal of Evaluation in Clinical Practice, 2007, 13: 254-258.
  • 9LEUNG T N, PANG M W, DALJIT S S. Fetal biometry in ethnic Chinese: Biparietal diameter, head circum- ference, abdominal circumference and femur length[J]. Ultrasound Obstet Gynecol, 2008, 31(3):321- 327.
  • 10WALD N J, GEORGE L, SMITH D, et al. Serum screening for Down syndrome between 8 and 14 weeks of pregnancy[J]. Br J Obstet Gynecol, 1996, 103(5):407- 412.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部